DPB Pharmaceuticals Ltd

DPB group of companies, DPB Antibiotics was established in 2005 with the aim to supply the growing pharmaceutical industry with quality API’s. With experience and insight of the Industry we are able to fulfill the industry’s needs. We as a company is specialized in providing pharmaceutical APIs, Excipients & FDF. With headquarter in Mumbai, India we have branch offices in China.

Today DPB has being successful in supplying to more than 1200 customers throughout India and to more than 300 customers in international market consisting of 40 countries. Many Indian manufacturers are closely associated with us for API supplies, apart from our Imports from different countries. Excellent management and relationships with the customers has made company to achieve the turnover of $ 125 million.

With the largest manufacturer & exporter of Isoxazoles group of APIs (Isoxazoles consist of Cloxacillin, Dicloxacillin, Flucloxacillin & Oxacillin )in the world, having backward integration of in-house productions of the side chain required for Isoxazoles i.e. CMIC,DICMIC, FCMIC & PMIC respectively. The capacity to manufacture almost 800 MT per annum of Isoxazoles.

With the largest installed capacity in the country to produce high quality oral enzymatic antibiotic APIs namely Ampicillin Trihydrate & Amoxicillin Trihydrate. The annual capacity is around 1400 MT.  DPB group plans to expand this capacity to about 2000 MT per annum. This plant is designed as per regulatory USFDA/EU-GMP guidelines. The company is the only manufacturer of the key antibiotic Amoxicillin - Potassium Clavulanate Sterile (5:1 Mixture) with proprietary technology in India.

DPB group is looking to tap the full potential of 180 MT per annum capacity with addition of high value products like meropenam sterile etc.

Our quality of API makes our company a Brand, unique and different from th...